nodes	percent_of_prediction	percent_of_DWPC	metapath
Trametinib—CYP2C8—Mometasone—atopic dermatitis	0.131	0.24	CbGbCtD
Trametinib—CYP2C8—Loratadine—atopic dermatitis	0.0751	0.138	CbGbCtD
Trametinib—CYP3A4—Pimecrolimus—atopic dermatitis	0.07	0.128	CbGbCtD
Trametinib—CYP2C8—Hydrocortisone—atopic dermatitis	0.0418	0.0767	CbGbCtD
Trametinib—CYP3A4—Tacrolimus—atopic dermatitis	0.0416	0.0764	CbGbCtD
Trametinib—CYP3A4—Loratadine—atopic dermatitis	0.0305	0.0559	CbGbCtD
Trametinib—CYP3A4—Methylprednisolone—atopic dermatitis	0.0279	0.0511	CbGbCtD
Trametinib—CYP2C8—Dexamethasone—atopic dermatitis	0.026	0.0477	CbGbCtD
Trametinib—CYP3A4—Triamcinolone—atopic dermatitis	0.0211	0.0387	CbGbCtD
Trametinib—CYP3A4—Betamethasone—atopic dermatitis	0.0181	0.0332	CbGbCtD
Trametinib—CYP3A4—Prednisolone—atopic dermatitis	0.0179	0.0328	CbGbCtD
Trametinib—CYP3A4—Hydrocortisone—atopic dermatitis	0.017	0.0311	CbGbCtD
Trametinib—CYP3A4—Prednisone—atopic dermatitis	0.0169	0.031	CbGbCtD
Trametinib—CYP3A4—Dexamethasone—atopic dermatitis	0.0105	0.0193	CbGbCtD
Trametinib—Insomnia—Tacrolimus—atopic dermatitis	0.000239	0.000916	CcSEcCtD
Trametinib—Haemoglobin—Prednisolone—atopic dermatitis	0.000239	0.000915	CcSEcCtD
Trametinib—Asthenia—Mometasone—atopic dermatitis	0.000238	0.000913	CcSEcCtD
Trametinib—Diarrhoea—Fluocinolone Acetonide—atopic dermatitis	0.000238	0.000912	CcSEcCtD
Trametinib—Haemorrhage—Prednisolone—atopic dermatitis	0.000238	0.000911	CcSEcCtD
Trametinib—Bradycardia—Hydrocortisone—atopic dermatitis	0.000236	0.000905	CcSEcCtD
Trametinib—Pruritus—Mometasone—atopic dermatitis	0.000235	0.0009	CcSEcCtD
Trametinib—Haemoglobin—Hydrocortisone—atopic dermatitis	0.000233	0.000894	CcSEcCtD
Trametinib—Haemorrhage—Hydrocortisone—atopic dermatitis	0.000232	0.000889	CcSEcCtD
Trametinib—Dizziness—Fluocinolone Acetonide—atopic dermatitis	0.00023	0.000881	CcSEcCtD
Trametinib—Nausea—Loratadine—atopic dermatitis	0.00023	0.000881	CcSEcCtD
Trametinib—Decreased appetite—Tacrolimus—atopic dermatitis	0.00023	0.00088	CcSEcCtD
Trametinib—Epistaxis—Triamcinolone—atopic dermatitis	0.00023	0.00088	CcSEcCtD
Trametinib—Dry skin—Prednisone—atopic dermatitis	0.000229	0.000877	CcSEcCtD
Trametinib—Gastrointestinal disorder—Tacrolimus—atopic dermatitis	0.000228	0.000874	CcSEcCtD
Trametinib—Connective tissue disorder—Hydrocortisone—atopic dermatitis	0.000228	0.000874	CcSEcCtD
Trametinib—Fatigue—Tacrolimus—atopic dermatitis	0.000228	0.000873	CcSEcCtD
Trametinib—Diarrhoea—Mometasone—atopic dermatitis	0.000227	0.000871	CcSEcCtD
Trametinib—Hypokalaemia—Prednisone—atopic dermatitis	0.000227	0.00087	CcSEcCtD
Trametinib—Constipation—Tacrolimus—atopic dermatitis	0.000226	0.000866	CcSEcCtD
Trametinib—Hyperglycaemia—Dexamethasone—atopic dermatitis	0.000223	0.000856	CcSEcCtD
Trametinib—Hyperglycaemia—Betamethasone—atopic dermatitis	0.000223	0.000856	CcSEcCtD
Trametinib—Bradycardia—Triamcinolone—atopic dermatitis	0.000222	0.000852	CcSEcCtD
Trametinib—Bradycardia—Methylprednisolone—atopic dermatitis	0.000222	0.000851	CcSEcCtD
Trametinib—Vomiting—Fluocinolone Acetonide—atopic dermatitis	0.000221	0.000847	CcSEcCtD
Trametinib—Alanine aminotransferase increased—Prednisone—atopic dermatitis	0.00022	0.000844	CcSEcCtD
Trametinib—Haemoglobin—Triamcinolone—atopic dermatitis	0.00022	0.000842	CcSEcCtD
Trametinib—Rash—Fluocinolone Acetonide—atopic dermatitis	0.000219	0.00084	CcSEcCtD
Trametinib—Haemoglobin—Methylprednisolone—atopic dermatitis	0.000219	0.00084	CcSEcCtD
Trametinib—Dermatitis—Fluocinolone Acetonide—atopic dermatitis	0.000219	0.000839	CcSEcCtD
Trametinib—Haemorrhage—Triamcinolone—atopic dermatitis	0.000219	0.000837	CcSEcCtD
Trametinib—Haemorrhage—Methylprednisolone—atopic dermatitis	0.000218	0.000835	CcSEcCtD
Trametinib—Headache—Fluocinolone Acetonide—atopic dermatitis	0.000218	0.000835	CcSEcCtD
Trametinib—Eye disorder—Hydrocortisone—atopic dermatitis	0.000217	0.000831	CcSEcCtD
Trametinib—Gastrointestinal pain—Tacrolimus—atopic dermatitis	0.000216	0.000828	CcSEcCtD
Trametinib—Connective tissue disorder—Methylprednisolone—atopic dermatitis	0.000214	0.000821	CcSEcCtD
Trametinib—Arrhythmia—Prednisolone—atopic dermatitis	0.000212	0.000813	CcSEcCtD
Trametinib—Pancreatitis—Prednisone—atopic dermatitis	0.000212	0.00081	CcSEcCtD
Trametinib—Vomiting—Mometasone—atopic dermatitis	0.000211	0.000809	CcSEcCtD
Trametinib—Rash—Mometasone—atopic dermatitis	0.000209	0.000802	CcSEcCtD
Trametinib—Dermatitis—Mometasone—atopic dermatitis	0.000209	0.000802	CcSEcCtD
Trametinib—Body temperature increased—Tacrolimus—atopic dermatitis	0.000209	0.000801	CcSEcCtD
Trametinib—Abdominal pain—Tacrolimus—atopic dermatitis	0.000209	0.000801	CcSEcCtD
Trametinib—Headache—Mometasone—atopic dermatitis	0.000208	0.000797	CcSEcCtD
Trametinib—Arrhythmia—Hydrocortisone—atopic dermatitis	0.000207	0.000794	CcSEcCtD
Trametinib—Erythema—Prednisolone—atopic dermatitis	0.000207	0.000793	CcSEcCtD
Trametinib—Nausea—Fluocinolone Acetonide—atopic dermatitis	0.000207	0.000792	CcSEcCtD
Trametinib—Eye disorder—Methylprednisolone—atopic dermatitis	0.000204	0.000781	CcSEcCtD
Trametinib—Mental disorder—Hydrocortisone—atopic dermatitis	0.000203	0.000779	CcSEcCtD
Trametinib—Cardiac disorder—Methylprednisolone—atopic dermatitis	0.000202	0.000775	CcSEcCtD
Trametinib—Erythema—Hydrocortisone—atopic dermatitis	0.000202	0.000774	CcSEcCtD
Trametinib—Malnutrition—Hydrocortisone—atopic dermatitis	0.000202	0.000774	CcSEcCtD
Trametinib—Bradycardia—Dexamethasone—atopic dermatitis	0.000202	0.000773	CcSEcCtD
Trametinib—Bradycardia—Betamethasone—atopic dermatitis	0.000202	0.000773	CcSEcCtD
Trametinib—Neutropenia—Prednisone—atopic dermatitis	0.000202	0.000773	CcSEcCtD
Trametinib—Haemoglobin—Dexamethasone—atopic dermatitis	0.000199	0.000764	CcSEcCtD
Trametinib—Haemoglobin—Betamethasone—atopic dermatitis	0.000199	0.000764	CcSEcCtD
Trametinib—Haemorrhage—Betamethasone—atopic dermatitis	0.000198	0.00076	CcSEcCtD
Trametinib—Haemorrhage—Dexamethasone—atopic dermatitis	0.000198	0.00076	CcSEcCtD
Trametinib—Angiopathy—Methylprednisolone—atopic dermatitis	0.000198	0.000758	CcSEcCtD
Trametinib—Nausea—Mometasone—atopic dermatitis	0.000197	0.000756	CcSEcCtD
Trametinib—Mediastinal disorder—Methylprednisolone—atopic dermatitis	0.000197	0.000753	CcSEcCtD
Trametinib—Arrhythmia—Triamcinolone—atopic dermatitis	0.000195	0.000748	CcSEcCtD
Trametinib—Vision blurred—Prednisolone—atopic dermatitis	0.000195	0.000747	CcSEcCtD
Trametinib—Arrhythmia—Methylprednisolone—atopic dermatitis	0.000195	0.000746	CcSEcCtD
Trametinib—Hyperglycaemia—Prednisone—atopic dermatitis	0.000195	0.000746	CcSEcCtD
Trametinib—Mental disorder—Methylprednisolone—atopic dermatitis	0.000191	0.000732	CcSEcCtD
Trametinib—Erythema—Triamcinolone—atopic dermatitis	0.00019	0.000729	CcSEcCtD
Trametinib—Erythema—Methylprednisolone—atopic dermatitis	0.00019	0.000727	CcSEcCtD
Trametinib—Malnutrition—Methylprednisolone—atopic dermatitis	0.00019	0.000727	CcSEcCtD
Trametinib—Asthenia—Tacrolimus—atopic dermatitis	0.00019	0.000727	CcSEcCtD
Trametinib—Pruritus—Tacrolimus—atopic dermatitis	0.000187	0.000717	CcSEcCtD
Trametinib—Dysgeusia—Triamcinolone—atopic dermatitis	0.000186	0.000714	CcSEcCtD
Trametinib—MAP2K1—neck—atopic dermatitis	0.000186	0.332	CbGeAlD
Trametinib—Eye disorder—Dexamethasone—atopic dermatitis	0.000185	0.00071	CcSEcCtD
Trametinib—Eye disorder—Betamethasone—atopic dermatitis	0.000185	0.00071	CcSEcCtD
Trametinib—Back pain—Triamcinolone—atopic dermatitis	0.000184	0.000705	CcSEcCtD
Trametinib—Diarrhoea—Tacrolimus—atopic dermatitis	0.000181	0.000693	CcSEcCtD
Trametinib—Angiopathy—Betamethasone—atopic dermatitis	0.00018	0.000689	CcSEcCtD
Trametinib—Angiopathy—Dexamethasone—atopic dermatitis	0.00018	0.000689	CcSEcCtD
Trametinib—Hypertension—Prednisolone—atopic dermatitis	0.000179	0.000684	CcSEcCtD
Trametinib—Arrhythmia—Dexamethasone—atopic dermatitis	0.000177	0.000679	CcSEcCtD
Trametinib—Arrhythmia—Betamethasone—atopic dermatitis	0.000177	0.000679	CcSEcCtD
Trametinib—Bradycardia—Prednisone—atopic dermatitis	0.000176	0.000674	CcSEcCtD
Trametinib—Dizziness—Tacrolimus—atopic dermatitis	0.000175	0.00067	CcSEcCtD
Trametinib—Hypertension—Hydrocortisone—atopic dermatitis	0.000174	0.000668	CcSEcCtD
Trametinib—Haemoglobin—Prednisone—atopic dermatitis	0.000174	0.000665	CcSEcCtD
Trametinib—Haemorrhage—Prednisone—atopic dermatitis	0.000173	0.000662	CcSEcCtD
Trametinib—Erythema—Dexamethasone—atopic dermatitis	0.000173	0.000661	CcSEcCtD
Trametinib—Erythema—Betamethasone—atopic dermatitis	0.000173	0.000661	CcSEcCtD
Trametinib—Myalgia—Hydrocortisone—atopic dermatitis	0.000172	0.000659	CcSEcCtD
Trametinib—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—atopic dermatitis	0.000171	0.000655	CcSEcCtD
Trametinib—Connective tissue disorder—Prednisone—atopic dermatitis	0.00017	0.00065	CcSEcCtD
Trametinib—Oedema—Prednisolone—atopic dermatitis	0.000169	0.000647	CcSEcCtD
Trametinib—Vomiting—Tacrolimus—atopic dermatitis	0.000168	0.000644	CcSEcCtD
Trametinib—Rash—Tacrolimus—atopic dermatitis	0.000167	0.000639	CcSEcCtD
Trametinib—Dermatitis—Tacrolimus—atopic dermatitis	0.000167	0.000638	CcSEcCtD
Trametinib—Cough—Triamcinolone—atopic dermatitis	0.000166	0.000636	CcSEcCtD
Trametinib—Headache—Tacrolimus—atopic dermatitis	0.000166	0.000634	CcSEcCtD
Trametinib—Oedema—Hydrocortisone—atopic dermatitis	0.000165	0.000632	CcSEcCtD
Trametinib—Hypertension—Triamcinolone—atopic dermatitis	0.000164	0.000629	CcSEcCtD
Trametinib—Hypertension—Methylprednisolone—atopic dermatitis	0.000164	0.000628	CcSEcCtD
Trametinib—Infection—Hydrocortisone—atopic dermatitis	0.000164	0.000628	CcSEcCtD
Trametinib—Hyperhidrosis—Prednisolone—atopic dermatitis	0.000163	0.000625	CcSEcCtD
Trametinib—Myalgia—Triamcinolone—atopic dermatitis	0.000162	0.000621	CcSEcCtD
Trametinib—Nervous system disorder—Hydrocortisone—atopic dermatitis	0.000162	0.00062	CcSEcCtD
Trametinib—Myalgia—Methylprednisolone—atopic dermatitis	0.000162	0.000619	CcSEcCtD
Trametinib—Arthralgia—Methylprednisolone—atopic dermatitis	0.000162	0.000619	CcSEcCtD
Trametinib—Eye disorder—Prednisone—atopic dermatitis	0.000161	0.000618	CcSEcCtD
Trametinib—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—atopic dermatitis	0.00016	0.000615	CcSEcCtD
Trametinib—Skin disorder—Hydrocortisone—atopic dermatitis	0.00016	0.000614	CcSEcCtD
Trametinib—Hyperhidrosis—Hydrocortisone—atopic dermatitis	0.000159	0.000611	CcSEcCtD
Trametinib—Dry mouth—Triamcinolone—atopic dermatitis	0.000158	0.000607	CcSEcCtD
Trametinib—Nausea—Tacrolimus—atopic dermatitis	0.000157	0.000602	CcSEcCtD
Trametinib—Angiopathy—Prednisone—atopic dermatitis	0.000157	0.0006	CcSEcCtD
Trametinib—Oedema—Triamcinolone—atopic dermatitis	0.000155	0.000595	CcSEcCtD
Trametinib—Arrhythmia—Prednisone—atopic dermatitis	0.000154	0.000591	CcSEcCtD
Trametinib—Infection—Triamcinolone—atopic dermatitis	0.000154	0.000591	CcSEcCtD
Trametinib—Infection—Methylprednisolone—atopic dermatitis	0.000154	0.00059	CcSEcCtD
Trametinib—Insomnia—Prednisolone—atopic dermatitis	0.000153	0.000585	CcSEcCtD
Trametinib—Nervous system disorder—Methylprednisolone—atopic dermatitis	0.000152	0.000582	CcSEcCtD
Trametinib—Mental disorder—Prednisone—atopic dermatitis	0.000151	0.00058	CcSEcCtD
Trametinib—Skin disorder—Methylprednisolone—atopic dermatitis	0.00015	0.000577	CcSEcCtD
Trametinib—Erythema—Prednisone—atopic dermatitis	0.00015	0.000576	CcSEcCtD
Trametinib—Malnutrition—Prednisone—atopic dermatitis	0.00015	0.000576	CcSEcCtD
Trametinib—Musculoskeletal discomfort—Hydrocortisone—atopic dermatitis	0.00015	0.000576	CcSEcCtD
Trametinib—Hyperhidrosis—Triamcinolone—atopic dermatitis	0.00015	0.000575	CcSEcCtD
Trametinib—Hyperhidrosis—Methylprednisolone—atopic dermatitis	0.00015	0.000574	CcSEcCtD
Trametinib—Insomnia—Hydrocortisone—atopic dermatitis	0.000149	0.000571	CcSEcCtD
Trametinib—Hypertension—Dexamethasone—atopic dermatitis	0.000149	0.000571	CcSEcCtD
Trametinib—Hypertension—Betamethasone—atopic dermatitis	0.000149	0.000571	CcSEcCtD
Trametinib—Myalgia—Betamethasone—atopic dermatitis	0.000147	0.000563	CcSEcCtD
Trametinib—Myalgia—Dexamethasone—atopic dermatitis	0.000147	0.000563	CcSEcCtD
Trametinib—Decreased appetite—Hydrocortisone—atopic dermatitis	0.000143	0.000549	CcSEcCtD
Trametinib—Gastrointestinal disorder—Hydrocortisone—atopic dermatitis	0.000142	0.000545	CcSEcCtD
Trametinib—Fatigue—Hydrocortisone—atopic dermatitis	0.000142	0.000545	CcSEcCtD
Trametinib—Vision blurred—Prednisone—atopic dermatitis	0.000142	0.000543	CcSEcCtD
Trametinib—Musculoskeletal discomfort—Triamcinolone—atopic dermatitis	0.000141	0.000542	CcSEcCtD
Trametinib—Musculoskeletal discomfort—Methylprednisolone—atopic dermatitis	0.000141	0.000541	CcSEcCtD
Trametinib—Oedema—Dexamethasone—atopic dermatitis	0.000141	0.00054	CcSEcCtD
Trametinib—Oedema—Betamethasone—atopic dermatitis	0.000141	0.00054	CcSEcCtD
Trametinib—Insomnia—Triamcinolone—atopic dermatitis	0.00014	0.000538	CcSEcCtD
Trametinib—Insomnia—Methylprednisolone—atopic dermatitis	0.00014	0.000537	CcSEcCtD
Trametinib—Infection—Betamethasone—atopic dermatitis	0.00014	0.000536	CcSEcCtD
Trametinib—Infection—Dexamethasone—atopic dermatitis	0.00014	0.000536	CcSEcCtD
Trametinib—Anaemia—Prednisone—atopic dermatitis	0.000139	0.000532	CcSEcCtD
Trametinib—Nervous system disorder—Dexamethasone—atopic dermatitis	0.000138	0.000529	CcSEcCtD
Trametinib—Nervous system disorder—Betamethasone—atopic dermatitis	0.000138	0.000529	CcSEcCtD
Trametinib—Thrombocytopenia—Betamethasone—atopic dermatitis	0.000138	0.000528	CcSEcCtD
Trametinib—Thrombocytopenia—Dexamethasone—atopic dermatitis	0.000138	0.000528	CcSEcCtD
Trametinib—Hyperhidrosis—Betamethasone—atopic dermatitis	0.000136	0.000522	CcSEcCtD
Trametinib—Hyperhidrosis—Dexamethasone—atopic dermatitis	0.000136	0.000522	CcSEcCtD
Trametinib—Gastrointestinal pain—Hydrocortisone—atopic dermatitis	0.000135	0.000517	CcSEcCtD
Trametinib—Fatigue—Triamcinolone—atopic dermatitis	0.000134	0.000513	CcSEcCtD
Trametinib—Fatigue—Methylprednisolone—atopic dermatitis	0.000134	0.000512	CcSEcCtD
Trametinib—MAP2K2—Disease—GLB1—atopic dermatitis	0.000131	0.000676	CbGpPWpGaD
Trametinib—Body temperature increased—Hydrocortisone—atopic dermatitis	0.00013	0.000499	CcSEcCtD
Trametinib—Abdominal pain—Hydrocortisone—atopic dermatitis	0.00013	0.000499	CcSEcCtD
Trametinib—Hypertension—Prednisone—atopic dermatitis	0.00013	0.000497	CcSEcCtD
Trametinib—MAP2K1—Toll-like Receptor Signaling Pathway—TNF—atopic dermatitis	0.000129	0.00067	CbGpPWpGaD
Trametinib—MAP2K2—MyD88 cascade initiated on plasma membrane—IL6—atopic dermatitis	0.000129	0.000669	CbGpPWpGaD
Trametinib—MAP2K2—IRS-mediated signalling—IL6—atopic dermatitis	0.000129	0.000669	CbGpPWpGaD
Trametinib—Musculoskeletal discomfort—Betamethasone—atopic dermatitis	0.000128	0.000492	CcSEcCtD
Trametinib—Musculoskeletal discomfort—Dexamethasone—atopic dermatitis	0.000128	0.000492	CcSEcCtD
Trametinib—Myalgia—Prednisone—atopic dermatitis	0.000128	0.00049	CcSEcCtD
Trametinib—Arthralgia—Prednisone—atopic dermatitis	0.000128	0.00049	CcSEcCtD
Trametinib—MAP2K2—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—IL6—atopic dermatitis	0.000128	0.000662	CbGpPWpGaD
Trametinib—MAP2K2—MAPK Signaling Pathway—IL1B—atopic dermatitis	0.000128	0.000662	CbGpPWpGaD
Trametinib—MAP2K1—Regulation of toll-like receptor signaling pathway—MAPK8—atopic dermatitis	0.000128	0.000661	CbGpPWpGaD
Trametinib—Insomnia—Betamethasone—atopic dermatitis	0.000127	0.000488	CcSEcCtD
Trametinib—Insomnia—Dexamethasone—atopic dermatitis	0.000127	0.000488	CcSEcCtD
Trametinib—Unspecified disorder of skin and subcutaneous tissue—Prednisone—atopic dermatitis	0.000127	0.000487	CcSEcCtD
Trametinib—Gastrointestinal pain—Methylprednisolone—atopic dermatitis	0.000127	0.000485	CcSEcCtD
Trametinib—MAP2K1—Toll-Like Receptors Cascades—MAPK8—atopic dermatitis	0.000126	0.000653	CbGpPWpGaD
Trametinib—MAP2K2—MyD88 dependent cascade initiated on endosome—IL6—atopic dermatitis	0.000126	0.00065	CbGpPWpGaD
Trametinib—MAP2K2—IRS-related events—IL6—atopic dermatitis	0.000126	0.00065	CbGpPWpGaD
Trametinib—MAP2K2—IRS-related events triggered by IGF1R—IL6—atopic dermatitis	0.000125	0.000644	CbGpPWpGaD
Trametinib—MAP2K1—BDNF signaling pathway—MAPK8—atopic dermatitis	0.000124	0.000642	CbGpPWpGaD
Trametinib—MAP2K2—TCR Signaling Pathway—IL6—atopic dermatitis	0.000123	0.000639	CbGpPWpGaD
Trametinib—Body temperature increased—Triamcinolone—atopic dermatitis	0.000123	0.00047	CcSEcCtD
Trametinib—Oedema—Prednisone—atopic dermatitis	0.000123	0.00047	CcSEcCtD
Trametinib—MAP2K1—Innate Immune System—CASP1—atopic dermatitis	0.000123	0.000635	CbGpPWpGaD
Trametinib—Abdominal pain—Methylprednisolone—atopic dermatitis	0.000122	0.000469	CcSEcCtD
Trametinib—Decreased appetite—Betamethasone—atopic dermatitis	0.000122	0.000469	CcSEcCtD
Trametinib—Decreased appetite—Dexamethasone—atopic dermatitis	0.000122	0.000469	CcSEcCtD
Trametinib—MAP2K2—Signaling by NGF—NFKBIA—atopic dermatitis	0.000122	0.000632	CbGpPWpGaD
Trametinib—MAP2K1—Disease—GLB1—atopic dermatitis	0.000122	0.000632	CbGpPWpGaD
Trametinib—MAP2K2—Insulin Signaling—MAPK8—atopic dermatitis	0.000122	0.000631	CbGpPWpGaD
Trametinib—Infection—Prednisone—atopic dermatitis	0.000122	0.000467	CcSEcCtD
Trametinib—Gastrointestinal disorder—Betamethasone—atopic dermatitis	0.000122	0.000466	CcSEcCtD
Trametinib—Gastrointestinal disorder—Dexamethasone—atopic dermatitis	0.000122	0.000466	CcSEcCtD
Trametinib—Fatigue—Betamethasone—atopic dermatitis	0.000121	0.000465	CcSEcCtD
Trametinib—Fatigue—Dexamethasone—atopic dermatitis	0.000121	0.000465	CcSEcCtD
Trametinib—MAP2K2—Insulin receptor signalling cascade—IL6—atopic dermatitis	0.000121	0.000628	CbGpPWpGaD
Trametinib—MAP2K2—Toll Like Receptor 9 (TLR9) Cascade—IL6—atopic dermatitis	0.000121	0.000628	CbGpPWpGaD
Trametinib—MAP2K2—IGF1R signaling cascade—IL6—atopic dermatitis	0.000121	0.000628	CbGpPWpGaD
Trametinib—MAP2K1—MyD88 cascade initiated on plasma membrane—IL6—atopic dermatitis	0.000121	0.000626	CbGpPWpGaD
Trametinib—MAP2K1—IRS-mediated signalling—IL6—atopic dermatitis	0.000121	0.000626	CbGpPWpGaD
Trametinib—MAP2K2—EGF/EGFR Signaling Pathway—MAPK8—atopic dermatitis	0.000121	0.000625	CbGpPWpGaD
Trametinib—MAP2K1—skin of body—atopic dermatitis	0.00012	0.215	CbGeAlD
Trametinib—Nervous system disorder—Prednisone—atopic dermatitis	0.00012	0.000461	CcSEcCtD
Trametinib—MAP2K1—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—IL6—atopic dermatitis	0.00012	0.00062	CbGpPWpGaD
Trametinib—MAP2K1—MAPK Signaling Pathway—IL1B—atopic dermatitis	0.00012	0.000619	CbGpPWpGaD
Trametinib—MAP2K2—MyD88:Mal cascade initiated on plasma membrane—IL6—atopic dermatitis	0.000119	0.000617	CbGpPWpGaD
Trametinib—Skin disorder—Prednisone—atopic dermatitis	0.000119	0.000457	CcSEcCtD
Trametinib—Hyperhidrosis—Prednisone—atopic dermatitis	0.000119	0.000454	CcSEcCtD
Trametinib—MAP2K2—Innate Immune System—TLR2—atopic dermatitis	0.000119	0.000614	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—KIF3A—atopic dermatitis	0.000119	0.000613	CbGpPWpGaD
Trametinib—Asthenia—Hydrocortisone—atopic dermatitis	0.000118	0.000453	CcSEcCtD
Trametinib—MAP2K1—MyD88 dependent cascade initiated on endosome—IL6—atopic dermatitis	0.000118	0.000608	CbGpPWpGaD
Trametinib—MAP2K1—IRS-related events—IL6—atopic dermatitis	0.000118	0.000608	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—CCL11—atopic dermatitis	0.000117	0.000607	CbGpPWpGaD
Trametinib—MAP2K2—MAPK Signaling Pathway—MAPK8—atopic dermatitis	0.000117	0.000607	CbGpPWpGaD
Trametinib—Pruritus—Hydrocortisone—atopic dermatitis	0.000117	0.000447	CcSEcCtD
Trametinib—MAP2K1—IRS-related events triggered by IGF1R—IL6—atopic dermatitis	0.000116	0.000603	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—FCER2—atopic dermatitis	0.000116	0.000599	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	0.000116	0.000598	CbGpPWpGaD
Trametinib—MAP2K1—TCR Signaling Pathway—IL6—atopic dermatitis	0.000115	0.000598	CbGpPWpGaD
Trametinib—Gastrointestinal pain—Betamethasone—atopic dermatitis	0.000115	0.000441	CcSEcCtD
Trametinib—Gastrointestinal pain—Dexamethasone—atopic dermatitis	0.000115	0.000441	CcSEcCtD
Trametinib—MAP2K2—MyD88-independent cascade—IL6—atopic dermatitis	0.000114	0.000592	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by NGF—NFKBIA—atopic dermatitis	0.000114	0.000592	CbGpPWpGaD
Trametinib—MAP2K1—Insulin Signaling—MAPK8—atopic dermatitis	0.000114	0.000591	CbGpPWpGaD
Trametinib—MAP2K1—IGF1R signaling cascade—IL6—atopic dermatitis	0.000113	0.000587	CbGpPWpGaD
Trametinib—MAP2K1—Insulin receptor signalling cascade—IL6—atopic dermatitis	0.000113	0.000587	CbGpPWpGaD
Trametinib—MAP2K1—Toll Like Receptor 9 (TLR9) Cascade—IL6—atopic dermatitis	0.000113	0.000587	CbGpPWpGaD
Trametinib—MAP2K1—EGF/EGFR Signaling Pathway—MAPK8—atopic dermatitis	0.000113	0.000585	CbGpPWpGaD
Trametinib—Diarrhoea—Hydrocortisone—atopic dermatitis	0.000113	0.000432	CcSEcCtD
Trametinib—MAP2K2—Fc epsilon receptor (FCERI) signaling—MAPK8—atopic dermatitis	0.000112	0.000582	CbGpPWpGaD
Trametinib—Musculoskeletal discomfort—Prednisone—atopic dermatitis	0.000112	0.000428	CcSEcCtD
Trametinib—MAP2K2—Toll-like Receptor Signaling Pathway—IL6—atopic dermatitis	0.000112	0.000578	CbGpPWpGaD
Trametinib—Dizziness—Prednisolone—atopic dermatitis	0.000112	0.000428	CcSEcCtD
Trametinib—MAP2K1—MyD88:Mal cascade initiated on plasma membrane—IL6—atopic dermatitis	0.000112	0.000577	CbGpPWpGaD
Trametinib—Asthenia—Triamcinolone—atopic dermatitis	0.000111	0.000427	CcSEcCtD
Trametinib—Body temperature increased—Dexamethasone—atopic dermatitis	0.000111	0.000427	CcSEcCtD
Trametinib—Body temperature increased—Betamethasone—atopic dermatitis	0.000111	0.000427	CcSEcCtD
Trametinib—Abdominal pain—Dexamethasone—atopic dermatitis	0.000111	0.000427	CcSEcCtD
Trametinib—Abdominal pain—Betamethasone—atopic dermatitis	0.000111	0.000427	CcSEcCtD
Trametinib—Asthenia—Methylprednisolone—atopic dermatitis	0.000111	0.000426	CcSEcCtD
Trametinib—Insomnia—Prednisone—atopic dermatitis	0.000111	0.000425	CcSEcCtD
Trametinib—MAP2K1—Innate Immune System—TLR2—atopic dermatitis	0.000111	0.000574	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—KIF3A—atopic dermatitis	0.000111	0.000574	CbGpPWpGaD
Trametinib—Pruritus—Triamcinolone—atopic dermatitis	0.00011	0.000421	CcSEcCtD
Trametinib—MAP2K1—Signaling by GPCR—CCL11—atopic dermatitis	0.00011	0.000568	CbGpPWpGaD
Trametinib—MAP2K1—MAPK Signaling Pathway—MAPK8—atopic dermatitis	0.00011	0.000568	CbGpPWpGaD
Trametinib—Pruritus—Methylprednisolone—atopic dermatitis	0.00011	0.00042	CcSEcCtD
Trametinib—Dizziness—Hydrocortisone—atopic dermatitis	0.000109	0.000418	CcSEcCtD
Trametinib—MAP2K1—Signaling Pathways—FCER2—atopic dermatitis	0.000108	0.00056	CbGpPWpGaD
Trametinib—MAP2K2—Regulation of toll-like receptor signaling pathway—TNF—atopic dermatitis	0.000108	0.000559	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—CCL22—atopic dermatitis	0.000108	0.000557	CbGpPWpGaD
Trametinib—MAP2K2—VEGFA-VEGFR2 Pathway—IL6—atopic dermatitis	0.000107	0.000556	CbGpPWpGaD
Trametinib—MAP2K1—MyD88-independent cascade—IL6—atopic dermatitis	0.000107	0.000554	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by Interleukins—IL6—atopic dermatitis	0.000107	0.000552	CbGpPWpGaD
Trametinib—Decreased appetite—Prednisone—atopic dermatitis	0.000107	0.000409	CcSEcCtD
Trametinib—Rash—Prednisolone—atopic dermatitis	0.000106	0.000408	CcSEcCtD
Trametinib—Dermatitis—Prednisolone—atopic dermatitis	0.000106	0.000407	CcSEcCtD
Trametinib—MAP2K2—Focal Adhesion—MAPK8—atopic dermatitis	0.000106	0.00055	CbGpPWpGaD
Trametinib—MAP2K2—skin of body—atopic dermatitis	0.000106	0.189	CbGeAlD
Trametinib—Diarrhoea—Methylprednisolone—atopic dermatitis	0.000106	0.000406	CcSEcCtD
Trametinib—Fatigue—Prednisone—atopic dermatitis	0.000106	0.000405	CcSEcCtD
Trametinib—Headache—Prednisolone—atopic dermatitis	0.000106	0.000405	CcSEcCtD
Trametinib—MAP2K1—Fc epsilon receptor (FCERI) signaling—MAPK8—atopic dermatitis	0.000105	0.000545	CbGpPWpGaD
Trametinib—Constipation—Prednisone—atopic dermatitis	0.000105	0.000402	CcSEcCtD
Trametinib—Vomiting—Hydrocortisone—atopic dermatitis	0.000105	0.000402	CcSEcCtD
Trametinib—MAP2K1—Toll-like Receptor Signaling Pathway—IL6—atopic dermatitis	0.000104	0.000541	CbGpPWpGaD
Trametinib—Rash—Hydrocortisone—atopic dermatitis	0.000104	0.000398	CcSEcCtD
Trametinib—Dermatitis—Hydrocortisone—atopic dermatitis	0.000104	0.000398	CcSEcCtD
Trametinib—Headache—Hydrocortisone—atopic dermatitis	0.000103	0.000396	CcSEcCtD
Trametinib—MAP2K2—Activated TLR4 signalling—IL6—atopic dermatitis	0.000103	0.000532	CbGpPWpGaD
Trametinib—Dizziness—Triamcinolone—atopic dermatitis	0.000103	0.000393	CcSEcCtD
Trametinib—Dizziness—Methylprednisolone—atopic dermatitis	0.000102	0.000393	CcSEcCtD
Trametinib—MAP2K1—Senescence and Autophagy in Cancer—IL6—atopic dermatitis	0.000102	0.000528	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by VEGF—IL6—atopic dermatitis	0.000101	0.000525	CbGpPWpGaD
Trametinib—Asthenia—Betamethasone—atopic dermatitis	0.000101	0.000387	CcSEcCtD
Trametinib—Asthenia—Dexamethasone—atopic dermatitis	0.000101	0.000387	CcSEcCtD
Trametinib—MAP2K1—Regulation of toll-like receptor signaling pathway—TNF—atopic dermatitis	0.000101	0.000523	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—STAT6—atopic dermatitis	0.000101	0.000521	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by Insulin receptor—IL6—atopic dermatitis	0.000101	0.000521	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—CCL22—atopic dermatitis	0.000101	0.000521	CbGpPWpGaD
Trametinib—MAP2K1—VEGFA-VEGFR2 Pathway—IL6—atopic dermatitis	0.000101	0.00052	CbGpPWpGaD
Trametinib—Gastrointestinal pain—Prednisone—atopic dermatitis	0.0001	0.000384	CcSEcCtD
Trametinib—Nausea—Prednisolone—atopic dermatitis	0.0001	0.000384	CcSEcCtD
Trametinib—MAP2K1—Signaling by Interleukins—IL6—atopic dermatitis	9.98e-05	0.000516	CbGpPWpGaD
Trametinib—Pruritus—Dexamethasone—atopic dermatitis	9.97e-05	0.000382	CcSEcCtD
Trametinib—Pruritus—Betamethasone—atopic dermatitis	9.97e-05	0.000382	CcSEcCtD
Trametinib—MAP2K1—Focal Adhesion—MAPK8—atopic dermatitis	9.94e-05	0.000515	CbGpPWpGaD
Trametinib—MAP2K1—Integrated Pancreatic Cancer Pathway—MAPK8—atopic dermatitis	9.9e-05	0.000513	CbGpPWpGaD
Trametinib—Vomiting—Triamcinolone—atopic dermatitis	9.87e-05	0.000378	CcSEcCtD
Trametinib—Vomiting—Methylprednisolone—atopic dermatitis	9.85e-05	0.000377	CcSEcCtD
Trametinib—MAP2K2—Immune System—CARD11—atopic dermatitis	9.8e-05	0.000507	CbGpPWpGaD
Trametinib—Nausea—Hydrocortisone—atopic dermatitis	9.79e-05	0.000375	CcSEcCtD
Trametinib—Rash—Triamcinolone—atopic dermatitis	9.79e-05	0.000375	CcSEcCtD
Trametinib—Dermatitis—Triamcinolone—atopic dermatitis	9.78e-05	0.000375	CcSEcCtD
Trametinib—Rash—Methylprednisolone—atopic dermatitis	9.77e-05	0.000374	CcSEcCtD
Trametinib—Dermatitis—Methylprednisolone—atopic dermatitis	9.76e-05	0.000374	CcSEcCtD
Trametinib—Headache—Triamcinolone—atopic dermatitis	9.73e-05	0.000373	CcSEcCtD
Trametinib—Headache—Methylprednisolone—atopic dermatitis	9.7e-05	0.000372	CcSEcCtD
Trametinib—Body temperature increased—Prednisone—atopic dermatitis	9.7e-05	0.000372	CcSEcCtD
Trametinib—Abdominal pain—Prednisone—atopic dermatitis	9.7e-05	0.000372	CcSEcCtD
Trametinib—MAP2K2—Toll Like Receptor 4 (TLR4) Cascade—IL6—atopic dermatitis	9.67e-05	0.000501	CbGpPWpGaD
Trametinib—Diarrhoea—Betamethasone—atopic dermatitis	9.64e-05	0.000369	CcSEcCtD
Trametinib—Diarrhoea—Dexamethasone—atopic dermatitis	9.64e-05	0.000369	CcSEcCtD
Trametinib—MAP2K1—Activated TLR4 signalling—IL6—atopic dermatitis	9.62e-05	0.000498	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—CCL27—atopic dermatitis	9.58e-05	0.000496	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—CCR3—atopic dermatitis	9.56e-05	0.000495	CbGpPWpGaD
Trametinib—MAP2K2—Cytokine Signaling in Immune system—IFNG—atopic dermatitis	9.53e-05	0.000493	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by VEGF—IL6—atopic dermatitis	9.49e-05	0.000491	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—STAT6—atopic dermatitis	9.43e-05	0.000488	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by Insulin receptor—IL6—atopic dermatitis	9.42e-05	0.000488	CbGpPWpGaD
Trametinib—Dizziness—Dexamethasone—atopic dermatitis	9.32e-05	0.000357	CcSEcCtD
Trametinib—Dizziness—Betamethasone—atopic dermatitis	9.32e-05	0.000357	CcSEcCtD
Trametinib—MAP2K2—MAPK Signaling Pathway—TNF—atopic dermatitis	9.28e-05	0.00048	CbGpPWpGaD
Trametinib—Nausea—Triamcinolone—atopic dermatitis	9.22e-05	0.000353	CcSEcCtD
Trametinib—Nausea—Methylprednisolone—atopic dermatitis	9.2e-05	0.000353	CcSEcCtD
Trametinib—MAP2K1—Immune System—CARD11—atopic dermatitis	9.17e-05	0.000475	CbGpPWpGaD
Trametinib—MAP2K1—Toll Like Receptor 4 (TLR4) Cascade—IL6—atopic dermatitis	9.05e-05	0.000468	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—CCL27—atopic dermatitis	8.97e-05	0.000464	CbGpPWpGaD
Trametinib—Vomiting—Dexamethasone—atopic dermatitis	8.96e-05	0.000343	CcSEcCtD
Trametinib—Vomiting—Betamethasone—atopic dermatitis	8.96e-05	0.000343	CcSEcCtD
Trametinib—MAP2K1—Signaling by GPCR—CCR3—atopic dermatitis	8.95e-05	0.000463	CbGpPWpGaD
Trametinib—MAP2K2—Developmental Biology—PPARA—atopic dermatitis	8.92e-05	0.000462	CbGpPWpGaD
Trametinib—MAP2K1—Cytokine Signaling in Immune system—IFNG—atopic dermatitis	8.92e-05	0.000461	CbGpPWpGaD
Trametinib—Rash—Dexamethasone—atopic dermatitis	8.88e-05	0.00034	CcSEcCtD
Trametinib—Rash—Betamethasone—atopic dermatitis	8.88e-05	0.00034	CcSEcCtD
Trametinib—Dermatitis—Betamethasone—atopic dermatitis	8.87e-05	0.00034	CcSEcCtD
Trametinib—Dermatitis—Dexamethasone—atopic dermatitis	8.87e-05	0.00034	CcSEcCtD
Trametinib—Headache—Dexamethasone—atopic dermatitis	8.83e-05	0.000338	CcSEcCtD
Trametinib—Headache—Betamethasone—atopic dermatitis	8.83e-05	0.000338	CcSEcCtD
Trametinib—Asthenia—Prednisone—atopic dermatitis	8.8e-05	0.000337	CcSEcCtD
Trametinib—MAP2K2—Disease—SLC11A1—atopic dermatitis	8.75e-05	0.000453	CbGpPWpGaD
Trametinib—MAP2K2—Regulation of toll-like receptor signaling pathway—IL6—atopic dermatitis	8.72e-05	0.000451	CbGpPWpGaD
Trametinib—MAP2K1—MAPK Signaling Pathway—TNF—atopic dermatitis	8.68e-05	0.000449	CbGpPWpGaD
Trametinib—Pruritus—Prednisone—atopic dermatitis	8.68e-05	0.000333	CcSEcCtD
Trametinib—MAP2K2—Toll-Like Receptors Cascades—IL6—atopic dermatitis	8.62e-05	0.000446	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by SCF-KIT—IL6—atopic dermatitis	8.62e-05	0.000446	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—CCL17—atopic dermatitis	8.6e-05	0.000445	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—TAC1—atopic dermatitis	8.52e-05	0.000441	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—NPS—atopic dermatitis	8.52e-05	0.000441	CbGpPWpGaD
Trametinib—MAP2K2—Cytokine Signaling in Immune system—IL1B—atopic dermatitis	8.5e-05	0.00044	CbGpPWpGaD
Trametinib—MAP2K2—Cytokine Signaling in Immune system—IL2—atopic dermatitis	8.47e-05	0.000438	CbGpPWpGaD
Trametinib—Diarrhoea—Prednisone—atopic dermatitis	8.39e-05	0.000322	CcSEcCtD
Trametinib—Nausea—Betamethasone—atopic dermatitis	8.37e-05	0.000321	CcSEcCtD
Trametinib—Nausea—Dexamethasone—atopic dermatitis	8.37e-05	0.000321	CcSEcCtD
Trametinib—MAP2K2—Signaling by GPCR—CXCR3—atopic dermatitis	8.36e-05	0.000433	CbGpPWpGaD
Trametinib—MAP2K1—Developmental Biology—PPARA—atopic dermatitis	8.35e-05	0.000432	CbGpPWpGaD
Trametinib—MAP2K2—Downstream signaling of activated FGFR—IL6—atopic dermatitis	8.24e-05	0.000427	CbGpPWpGaD
Trametinib—MAP2K1—Disease—SLC11A1—atopic dermatitis	8.18e-05	0.000424	CbGpPWpGaD
Trametinib—MAP2K1—Regulation of toll-like receptor signaling pathway—IL6—atopic dermatitis	8.15e-05	0.000422	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by ERBB4—IL6—atopic dermatitis	8.11e-05	0.00042	CbGpPWpGaD
Trametinib—Dizziness—Prednisone—atopic dermatitis	8.11e-05	0.000311	CcSEcCtD
Trametinib—MAP2K1—Signaling by SCF-KIT—IL6—atopic dermatitis	8.06e-05	0.000417	CbGpPWpGaD
Trametinib—MAP2K1—Toll-Like Receptors Cascades—IL6—atopic dermatitis	8.06e-05	0.000417	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—CCL17—atopic dermatitis	8.04e-05	0.000416	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—NPS—atopic dermatitis	7.97e-05	0.000413	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—TAC1—atopic dermatitis	7.97e-05	0.000413	CbGpPWpGaD
Trametinib—MAP2K1—Cytokine Signaling in Immune system—IL1B—atopic dermatitis	7.95e-05	0.000412	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—IL5—atopic dermatitis	7.92e-05	0.00041	CbGpPWpGaD
Trametinib—MAP2K1—Cytokine Signaling in Immune system—IL2—atopic dermatitis	7.92e-05	0.00041	CbGpPWpGaD
Trametinib—MAP2K1—head—atopic dermatitis	7.86e-05	0.14	CbGeAlD
Trametinib—MAP2K1—Integrated Pancreatic Cancer Pathway—TNF—atopic dermatitis	7.84e-05	0.000406	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—CXCR3—atopic dermatitis	7.82e-05	0.000405	CbGpPWpGaD
Trametinib—Vomiting—Prednisone—atopic dermatitis	7.8e-05	0.000299	CcSEcCtD
Trametinib—MAP2K2—Downstream signal transduction—IL6—atopic dermatitis	7.75e-05	0.000401	CbGpPWpGaD
Trametinib—Rash—Prednisone—atopic dermatitis	7.74e-05	0.000296	CcSEcCtD
Trametinib—Dermatitis—Prednisone—atopic dermatitis	7.73e-05	0.000296	CcSEcCtD
Trametinib—MAP2K1—Downstream signaling of activated FGFR—IL6—atopic dermatitis	7.71e-05	0.000399	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by FGFR—IL6—atopic dermatitis	7.71e-05	0.000399	CbGpPWpGaD
Trametinib—Headache—Prednisone—atopic dermatitis	7.69e-05	0.000294	CcSEcCtD
Trametinib—MAP2K2—Signaling by ERBB2—IL6—atopic dermatitis	7.67e-05	0.000397	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by NGF—MAPK8—atopic dermatitis	7.66e-05	0.000397	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—KIF3A—atopic dermatitis	7.66e-05	0.000397	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—CASP1—atopic dermatitis	7.64e-05	0.000395	CbGpPWpGaD
Trametinib—MAP2K2—DAP12 signaling—IL6—atopic dermatitis	7.64e-05	0.000395	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by ERBB4—IL6—atopic dermatitis	7.59e-05	0.000393	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—IL5—atopic dermatitis	7.41e-05	0.000384	CbGpPWpGaD
Trametinib—Nausea—Prednisone—atopic dermatitis	7.29e-05	0.000279	CcSEcCtD
Trametinib—MAP2K1—Downstream signal transduction—IL6—atopic dermatitis	7.25e-05	0.000375	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—IL5—atopic dermatitis	7.24e-05	0.000375	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by FGFR—IL6—atopic dermatitis	7.21e-05	0.000373	CbGpPWpGaD
Trametinib—MAP2K2—DAP12 interactions—IL6—atopic dermatitis	7.18e-05	0.000372	CbGpPWpGaD
Trametinib—MAP2K2—Fc epsilon receptor (FCERI) signaling—IL6—atopic dermatitis	7.18e-05	0.000372	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by FGFR in disease—IL6—atopic dermatitis	7.18e-05	0.000372	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by ERBB2—IL6—atopic dermatitis	7.18e-05	0.000372	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by NGF—MAPK8—atopic dermatitis	7.17e-05	0.000371	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—KIF3A—atopic dermatitis	7.17e-05	0.000371	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—CASP1—atopic dermatitis	7.14e-05	0.00037	CbGpPWpGaD
Trametinib—MAP2K1—DAP12 signaling—IL6—atopic dermatitis	7.14e-05	0.00037	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by EGFR—IL6—atopic dermatitis	7.12e-05	0.000368	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by EGFR in Cancer—IL6—atopic dermatitis	7.06e-05	0.000365	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by PDGF—IL6—atopic dermatitis	7.03e-05	0.000364	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—NFKBIA—atopic dermatitis	6.97e-05	0.000361	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—CCL11—atopic dermatitis	6.93e-05	0.000359	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—CMA1—atopic dermatitis	6.93e-05	0.000359	CbGpPWpGaD
Trametinib—MAP2K2—head—atopic dermatitis	6.92e-05	0.123	CbGeAlD
Trametinib—MAP2K2—Immune System—TLR2—atopic dermatitis	6.91e-05	0.000357	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—IL5—atopic dermatitis	6.77e-05	0.000351	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—CXCL10—atopic dermatitis	6.76e-05	0.00035	CbGpPWpGaD
Trametinib—MAP2K1—DAP12 interactions—IL6—atopic dermatitis	6.72e-05	0.000348	CbGpPWpGaD
Trametinib—MAP2K1—Fc epsilon receptor (FCERI) signaling—IL6—atopic dermatitis	6.72e-05	0.000348	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by FGFR in disease—IL6—atopic dermatitis	6.72e-05	0.000348	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by EGFR—IL6—atopic dermatitis	6.66e-05	0.000345	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by EGFR in Cancer—IL6—atopic dermatitis	6.6e-05	0.000342	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by PDGF—IL6—atopic dermatitis	6.57e-05	0.00034	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—NFKBIA—atopic dermatitis	6.52e-05	0.000337	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—STAT6—atopic dermatitis	6.51e-05	0.000337	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—CD79A—atopic dermatitis	6.49e-05	0.000336	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—CMA1—atopic dermatitis	6.48e-05	0.000336	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—CCL11—atopic dermatitis	6.48e-05	0.000336	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—TLR2—atopic dermatitis	6.46e-05	0.000334	CbGpPWpGaD
Trametinib—MAP2K2—NGF signalling via TRKA from the plasma membrane—IL6—atopic dermatitis	6.36e-05	0.000329	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—CXCL10—atopic dermatitis	6.32e-05	0.000327	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—CASP8—atopic dermatitis	6.28e-05	0.000325	CbGpPWpGaD
Trametinib—MAP2K2—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	6.15e-05	0.000318	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—STAT6—atopic dermatitis	6.09e-05	0.000315	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—CD79A—atopic dermatitis	6.07e-05	0.000314	CbGpPWpGaD
Trametinib—MAP2K1—NGF signalling via TRKA from the plasma membrane—IL6—atopic dermatitis	5.95e-05	0.000308	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—CASP8—atopic dermatitis	5.88e-05	0.000304	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—CCL5—atopic dermatitis	5.82e-05	0.000301	CbGpPWpGaD
Trametinib—MAP2K1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	5.75e-05	0.000298	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—CCR3—atopic dermatitis	5.65e-05	0.000292	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—CCL5—atopic dermatitis	5.44e-05	0.000282	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—IL18—atopic dermatitis	5.31e-05	0.000275	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—CCR3—atopic dermatitis	5.28e-05	0.000274	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—CCR5—atopic dermatitis	5.24e-05	0.000271	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—CD8A—atopic dermatitis	5.23e-05	0.000271	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—CD4—atopic dermatitis	5.16e-05	0.000267	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—GLB1—atopic dermatitis	5.15e-05	0.000266	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—NPS—atopic dermatitis	5.03e-05	0.000261	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—TAC1—atopic dermatitis	5.03e-05	0.000261	CbGpPWpGaD
Trametinib—MAP2K2—Cytokine Signaling in Immune system—IL6—atopic dermatitis	4.98e-05	0.000258	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—IL18—atopic dermatitis	4.97e-05	0.000257	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—CXCR3—atopic dermatitis	4.94e-05	0.000256	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—ADSL—atopic dermatitis	4.94e-05	0.000255	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—CCR5—atopic dermatitis	4.9e-05	0.000254	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—CD8A—atopic dermatitis	4.9e-05	0.000253	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by NGF—IL6—atopic dermatitis	4.89e-05	0.000253	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—CD4—atopic dermatitis	4.83e-05	0.00025	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—TAC1—atopic dermatitis	4.71e-05	0.000244	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—NPS—atopic dermatitis	4.71e-05	0.000244	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—IL5—atopic dermatitis	4.68e-05	0.000242	CbGpPWpGaD
Trametinib—MAP2K1—Cytokine Signaling in Immune system—IL6—atopic dermatitis	4.66e-05	0.000241	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—CXCR3—atopic dermatitis	4.62e-05	0.000239	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by NGF—IL6—atopic dermatitis	4.58e-05	0.000237	CbGpPWpGaD
Trametinib—MAP2K2—Axon guidance—IL6—atopic dermatitis	4.43e-05	0.000229	CbGpPWpGaD
Trametinib—MAP2K2—Disease—CCR5—atopic dermatitis	4.42e-05	0.000229	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—IL5—atopic dermatitis	4.38e-05	0.000227	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—MAPK8—atopic dermatitis	4.37e-05	0.000226	CbGpPWpGaD
Trametinib—MAP2K1—Axon guidance—IL6—atopic dermatitis	4.14e-05	0.000214	CbGpPWpGaD
Trametinib—MAP2K1—Disease—CCR5—atopic dermatitis	4.13e-05	0.000214	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—MAPK8—atopic dermatitis	4.09e-05	0.000212	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—NFKBIA—atopic dermatitis	4.06e-05	0.00021	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—CXCL10—atopic dermatitis	3.99e-05	0.000207	CbGpPWpGaD
Trametinib—MAP2K2—Developmental Biology—TNF—atopic dermatitis	3.92e-05	0.000203	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—NFKBIA—atopic dermatitis	3.8e-05	0.000197	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	3.75e-05	0.000194	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—CXCL10—atopic dermatitis	3.73e-05	0.000193	CbGpPWpGaD
Trametinib—MAP2K1—Developmental Biology—TNF—atopic dermatitis	3.66e-05	0.00019	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—CASP8—atopic dermatitis	3.66e-05	0.000189	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—CCL5—atopic dermatitis	3.44e-05	0.000178	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—CASP8—atopic dermatitis	3.42e-05	0.000177	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—CCL5—atopic dermatitis	3.21e-05	0.000166	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—NGF—atopic dermatitis	3.18e-05	0.000165	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—CXCL8—atopic dermatitis	3.17e-05	0.000164	CbGpPWpGaD
Trametinib—MAP2K2—Developmental Biology—IL6—atopic dermatitis	3.16e-05	0.000164	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—IFNG—atopic dermatitis	3.11e-05	0.000161	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—CCR5—atopic dermatitis	3.09e-05	0.00016	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—IL2—atopic dermatitis	3.03e-05	0.000157	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—CD4—atopic dermatitis	3.01e-05	0.000156	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—NGF—atopic dermatitis	2.98e-05	0.000154	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—CXCL8—atopic dermatitis	2.96e-05	0.000153	CbGpPWpGaD
Trametinib—MAP2K1—Developmental Biology—IL6—atopic dermatitis	2.96e-05	0.000153	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—IFNG—atopic dermatitis	2.91e-05	0.000151	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—CCR5—atopic dermatitis	2.9e-05	0.00015	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—IL2—atopic dermatitis	2.83e-05	0.000147	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—CD4—atopic dermatitis	2.81e-05	0.000146	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—IL6—atopic dermatitis	2.79e-05	0.000144	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—IL1B—atopic dermatitis	2.78e-05	0.000144	CbGpPWpGaD
Trametinib—MAP2K2—Disease—CD4—atopic dermatitis	2.78e-05	0.000144	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—IL2—atopic dermatitis	2.77e-05	0.000143	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—GLB1—atopic dermatitis	2.76e-05	0.000143	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—ADSL—atopic dermatitis	2.65e-05	0.000137	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—NFKBIA—atopic dermatitis	2.62e-05	0.000136	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—IL6—atopic dermatitis	2.61e-05	0.000135	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—IL1B—atopic dermatitis	2.6e-05	0.000134	CbGpPWpGaD
Trametinib—MAP2K1—Disease—CD4—atopic dermatitis	2.6e-05	0.000134	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—IL2—atopic dermatitis	2.59e-05	0.000134	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—MAPK8—atopic dermatitis	2.55e-05	0.000132	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—NFKBIA—atopic dermatitis	2.45e-05	0.000127	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—MAPK8—atopic dermatitis	2.38e-05	0.000123	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—CXCL8—atopic dermatitis	1.87e-05	9.68e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—IL2—atopic dermatitis	1.79e-05	9.25e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—IL6—atopic dermatitis	1.78e-05	9.21e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—CXCL8—atopic dermatitis	1.75e-05	9.06e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—IL2—atopic dermatitis	1.67e-05	8.66e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—PPARA—atopic dermatitis	1.67e-05	8.65e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—IL6—atopic dermatitis	1.66e-05	8.62e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—MAPK8—atopic dermatitis	1.65e-05	8.52e-05	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—IL6—atopic dermatitis	1.63e-05	8.41e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—MAPK8—atopic dermatitis	1.54e-05	7.97e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—IL6—atopic dermatitis	1.52e-05	7.87e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—IL6—atopic dermatitis	1.5e-05	7.77e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—IL6—atopic dermatitis	1.4e-05	7.27e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—IL6—atopic dermatitis	1.05e-05	5.44e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—IL6—atopic dermatitis	9.83e-06	5.09e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—PPARA—atopic dermatitis	8.97e-06	4.64e-05	CbGpPWpGaD
